ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement
November 26, 2025 | ESMO 2025, Scientific Engagement
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.
At this year’s European Society for Medical Oncology (ESMO) Congress, the spotlight wasn’t only on data, it was on design. Across the exhibition floor, exhibitors reimagined how science could be experienced, not just explained.
Inizio experts Ellen Maxwell (Scientific Strategy Director, Ashfield MedComms, Inizio Medical), Stephanie Tortell (President, Ashfield MedComms, Inizio Medical) and Katie Streten (Head of Creative Strategy, Emota) observed a clear shift: from communication to connection, from presentation to participation.
Designing for engagement: Turning booths into scientific experiences
From booth layouts to interactive displays, design took center stage at ESMO – not as decoration, but as a driver of understanding.
“The most compelling booths weren’t the flashiest,” Ellen noted, “Every interactive element, from digital journeys to hands-on models, served a clear purpose: to make science tangible.”
Stephanie added, “And that purpose extended to design strategy itself. Visibility, flow, and comfort were treated as integral to storytelling. When you design around how people move, think, and feel, the experience becomes effortless and unforgettable.”
Together, they noted how thoughtful design turned passive observation into active understanding, signaling a new era of scientific engagement.
Using emotion to enhance scientific storytelling and engagement
Beyond form and function, exhibitors tapped into feeling – recognizing that emotion can make scientific stories unforgettable.
“We’re seeing science expressed with emotional intelligence,” Katie reflected. “Visuals, color, and motion now work together to create moments of feeling as much as fact.”
Ellen agreed, “And accessibility is part of that emotion. In busy congress spaces, subtitled visuals and clean motion graphics ensure everyone can engage, no matter the noise or language barriers.”
Their shared insight: the most effective storytelling isn’t about spectacle, but rather about empathy, clarity, and connection.
Visual identity at ESMO 2025: Confidence through color and form
That emotional energy extended to the visual identity of the congress itself, where confidence and clarity shone through in every detail.
“There’s been a definite shift in aesthetic tone,” Stephanie observed. “We’ve moved from softness to strength, and from subtle graphics to confident, assertive visuals that reflect precision and purpose.”
Katie continued, “That confidence shows in color too. Pharma brands are embracing vibrant hues and distinctive identities. But the best examples used color with intention instead of just decoration in order to amplify the story, not distract from it.”
This balance of creativity and credibility defined the visual language of ESMO 2025.
Sustainable design in scientific exhibits: ESMO 2025 trends
Alongside creativity came conscience. Sustainability was no longer a differentiator, but a shared expectation.
Ellen observed, “Sustainability has matured beyond messaging. Reusable materials, modular builds, and transparent environmental commitments are now baseline expectations.”
Stephanie agreed, adding, “And that’s inspiring. It shows how creativity and responsibility don’t have to simply coexist but actually reinforce each other. Conscious design isn’t a constraint; it’s a catalyst for smarter solutions.”
Together, they reflected on how environmental awareness is reshaping the aesthetics and ethics of scientific spaces.
Human-centered design: Creating meaningful congress experiences
And at the heart of it all was the human experience – because even in data-driven spaces, connection is what people remember.
Katie reflected, “Comfort remains the quiet driver of engagement. A seat, a drink, or a place to pause are the moments that turn interaction into conversation.”
Stephanie added, “Exactly. Hospitality is about creating calm within the chaos. When people feel cared for, they’re more open, more curious, and more present.”
In a setting driven by data, these human touches remind us that empathy is still science’s most powerful connector.
From information to inspiration: Redefining scientific engagement
Across ESMO 2025, one message rang clear: connection is the new currency of communication. Science alone informs, but science paired with design, emotion, and sustainability inspires.
As Ellen, Stephanie, and Katie each observed, the future of congress engagement lies in integration and blending creativity and clarity to make every interaction meaningful.
At Inizio, we believe this is where innovation truly happens: when stories of science become experiences that stay with people long after they leave the floor.
For a complementary perspective on the scientific and strategic trends shaping oncology, explore ESMO 2025 Insights: Emerging Oncology Trends Highlighting the Need for Precision Medical Affairs by Rüdiger Papsch, Partner, Medical & Scientific Affairs, Inizio Advisory.
And for a deeper look into the creative shifts redefining experiential design at pharma congresses, take a look at Four Creative Shifts from ESMO: What’s Next for Experiential Design in Pharma by Katie Streten, Head of Creative Strategy at Emota (part of Inizio Engage).
Ready to elevate your congress presence?
Let’s talk about transforming science into story. Learn more about our full-service congress solution, or contact us today.
This content was provided by Inizio
Company Details
Latest Content from Inizio
How we elevated HCP market research engagement and insights using AI avatars for an immersive experience
Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...
How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution
PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...
The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI
Authored by Paul Reed and Anabelle Gall
Latest European developments and new talent at Research Partnership
Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...
New syndicated report – Living with Ulcerative Colitis 2024
Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...
Webcast: AI in MRX: Harnessing the power of AI + people
Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...
Navigating challenges of MedTech research with rare-disease patients
Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.
Product launch: What market research when?
Get the insights you need, when you need them, for your product launch planning
Therapy Watch launches new tracker covering Alzheimer’s Disease
The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.
Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)
Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.